Fig. 2From: Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiencySurvey reported extent of growth delay experienced by children before treatment with olipudase alfa (a) and changes in growth delay in response to treatment (b). Both cohorts were n = 10Back to article page